FDA inspection
QuVa Pharma, Inc.: FDA inspection ending Mar 14, 2019
FDA inspection 1083122 · Official Action Indicated (OAI) · Temple, TX
Key facts
| Inspection ID | 1083122 |
|---|---|
| Firm | QuVa Pharma, Inc. |
| FEI number | 3002468086 |
| Address | 5920 S General Bruce Dr Ste 100 |
| City | Temple |
| State | TX |
| ZIP | 76502 |
| Country | United States |
| Fiscal year | 2019 |
| Inspection end date | Mar 14, 2019 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data